Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice

[1]  G. Spinetti,et al.  Diabetes Mellitus Induces Bone Marrow Microangiopathy , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Avogaro,et al.  Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes , 2010, Diabetes Care.

[3]  A. Langheinrich,et al.  Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression , 2010, Basic Research in Cardiology.

[4]  M. Boulton,et al.  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock , 2009, The Journal of experimental medicine.

[5]  E. Friedrich,et al.  Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease , 2009, Basic Research in Cardiology.

[6]  A. Zeiher,et al.  High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. , 2008, Journal of molecular and cellular cardiology.

[7]  A. Zeiher,et al.  Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors , 2008, Basic Research in Cardiology.

[8]  S. Dimmeler,et al.  Aging and disease as modifiers of efficacy of cell therapy. , 2008, Circulation research.

[9]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[10]  Stefanie Dimmeler,et al.  Cell-Based Therapy of Myocardial Infarction , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Y. Yoon,et al.  Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.

[12]  Ajay S. Gulati,et al.  Proinflammatory cytokine expression in cyclooxygenase-2-deficient primary osteoblasts. , 2007, Journal of endodontics.

[13]  G. Spangrude,et al.  Hematopoietic stem cells: generation and self-renewal , 2007, Cell Death and Differentiation.

[14]  N. Sengupta,et al.  Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells , 2007, Diabetes.

[15]  Ajay S. Gulati,et al.  The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption. , 2007, Journal of endodontics.

[16]  P. Galuppo,et al.  Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.

[17]  R. Kaplan,et al.  Niche-to-niche migration of bone-marrow-derived cells. , 2007, Trends in molecular medicine.

[18]  J. Chun,et al.  Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  A. Avogaro,et al.  Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats , 2006, Diabetologia.

[20]  A. Avogaro,et al.  Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Richard T. Lee,et al.  Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Ari Elson,et al.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.

[23]  Linheng Li,et al.  The stem cell niches in bone. , 2006, The Journal of clinical investigation.

[24]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[25]  K. Moore,et al.  Stem Cells and Their Niches , 2006, Science.

[26]  K. Maruyama,et al.  Endothelial Progenitor Thrombospondin-1 Mediates Diabetes-Induced Delay in Reendothelialization Following Arterial Injury , 2006, Circulation research.

[27]  P. Dentelli,et al.  p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes* , 2006, Journal of Biological Chemistry.

[28]  Stefanie Dimmeler,et al.  Impaired CXCR4 Signaling Contributes to the Reduced Neovascularization Capacity of Endothelial Progenitor Cells From Patients With Coronary Artery Disease , 2005, Circulation research.

[29]  S. Rafii,et al.  The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.

[30]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[31]  A. Avogaro,et al.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.

[32]  M. Dunnwald,et al.  Obese Diabetic Mouse Environment Differentially Affects Primitive and Monocytic Endothelial Cell Progenitors , 2005, Stem cells.

[33]  G. Schuler,et al.  Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Zeiher,et al.  p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells , 2005, Circulation.

[35]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[36]  B. Lévy,et al.  Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.

[37]  Sean J Morrison,et al.  Bmi1, stem cells, and senescence regulation. , 2004, The Journal of clinical investigation.

[38]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[39]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[40]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[41]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[42]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[43]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[44]  P. Anversa,et al.  IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. , 2001, Diabetes.

[45]  V. Speirs.  Matrix metalloproteinases and angiogenesis , 2000, Breast Cancer Research.

[46]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[47]  J. Isner,et al.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.

[48]  F. Logerfo,et al.  Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. , 1998, Journal of vascular surgery.

[49]  R. Dantzer,et al.  Insulin Growth Factor‐I Inhibits Apoptosis in Hematopoietic: Progenitor Cells Implications in Thymic Aging a , 1998, Annals of the New York Academy of Sciences.

[50]  I. Weissman,et al.  The biology of hematopoietic stem cells. , 1995, Annual review of cell and developmental biology.

[51]  S. Chakrabarti,et al.  Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. , 1988, Endocrinology.